Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell ...

Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.

Penn-Trafford sophomore Abby Rayman and her team of fundraisers generated more than $18,000 for the Leukemia and Lymphoma Society, exceeding the $10,000 goal she set in February. A national nonprofit ...

After living with lymphoma for 15 and a half years, my doctor has suggested reducing the dose of my medication and possibly ...

The patient was diagnosed with nongerminal-center B cell diffuse large B-cell lymphoma (DLBCL) 1 year after being diagnosed with primary biliary cholangitis (PBC).

Two staff members shaved their heads on Wednesday to support 17-year-old Burley High School junior Pamela Cardona, who was ...

Discover how innovative lymphoma treatments are transforming patient outcomes, from targeted therapies to immunotherapy ...

Treatment consisted of 4-6 cycles of dose-dense intensive chemotherapy incorporating hyperfractionated cyclophosphamide/ifosfamide, high-dose cytarabine and methotrexate, doxorubicin, etoposide, ...

Memo del Bosque was diagnosed with Hodgkin’s lymphoma in 2017. This aggressive cancer primarily affects white blood cells ...

Clinical approaches to non-Hodgkin lymphoma in younger and older patient groups generally do not differ, according to Andrew Evens, DO, but he emphasized the need for deeper clinical insights into ...

The reality star, 28, who appeared on the E4 show last year, shared in an Instagram video that she first went under the knife ...

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...